16-2090971-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001009944.3(PKD1):​c.11916C>G​(p.Arg3972Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000702 in 1,543,088 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R3972R) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0035 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00039 ( 3 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.650

Publications

7 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 16-2090971-G-C is Benign according to our data. Variant chr16-2090971-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 811148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.65 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00351 (534/152200) while in subpopulation AFR AF = 0.0123 (512/41528). AF 95% confidence interval is 0.0114. There are 1 homozygotes in GnomAd4. There are 249 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.11916C>G p.Arg3972Arg synonymous_variant Exon 43 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.11916C>G p.Arg3972Arg synonymous_variant Exon 43 of 46 1 NM_001009944.3 ENSP00000262304.4

Frequencies

GnomAD3 genomes
AF:
0.00352
AC:
535
AN:
152082
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0124
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000917
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000681
AC:
94
AN:
138110
AF XY:
0.000526
show subpopulations
Gnomad AFR exome
AF:
0.0109
Gnomad AMR exome
AF:
0.000481
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000172
Gnomad NFE exome
AF:
0.0000562
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000395
AC:
549
AN:
1390888
Hom.:
3
Cov.:
34
AF XY:
0.000342
AC XY:
235
AN XY:
687370
show subpopulations
African (AFR)
AF:
0.0125
AC:
399
AN:
31990
American (AMR)
AF:
0.000578
AC:
21
AN:
36350
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25146
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36214
South Asian (SAS)
AF:
0.0000248
AC:
2
AN:
80588
European-Finnish (FIN)
AF:
0.000117
AC:
4
AN:
34198
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5686
European-Non Finnish (NFE)
AF:
0.0000600
AC:
65
AN:
1082594
Other (OTH)
AF:
0.000981
AC:
57
AN:
58122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00351
AC:
534
AN:
152200
Hom.:
1
Cov.:
34
AF XY:
0.00335
AC XY:
249
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.0123
AC:
512
AN:
41528
American (AMR)
AF:
0.000916
AC:
14
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000736
AC:
5
AN:
67974
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000949
Hom.:
12
Bravo
AF:
0.00416

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Polycystic kidney disease, adult type Benign:2
Oct 01, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PKD1: BS1, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Apr 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Polycystic kidney disease Benign:1
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 p.Arg3972= variant was identified in 11 of 460 proband chromosomes (frequency: 0.0239) from individuals or families with PKD, and the study classified the variant as a polymorphism (Rossetti 2012). The variant was also identified in dbSNP (ID: rs77634115) as “With Benign allele”, ClinVar (1x as benign by Prevention Genetics), Clinvitae (as benign), ADPKD Mutation Database (as likely neutral). In addition, a different nucleotide change, c.11916C>T, with the same protein consequence, has been classified as benign in several databases, including ClinVar and Clinvitae. The variant was not identified in LOVD 3.0, and PKD1-LOVD databases. The variant was identified in control databases in 200 of 164424 chromosomes at a frequency of 0.0012, in the following populations: African in 181 (1 homozygous) of 15410 chromosomes (freq: 0.012), Latino in 12 of 25050 chromosomes (freq. 0.0005), Other in 1 of 4606 chromosomes (freq. 0.0002), European (Finnish) in 4 of 66128 (freq. 0.0001), European (Non-Finnish) in 4 of 66128 chromosomes (freq. 0.00006), and South Asian in 1 of 23662 chromosomes (freq. 0.00004), increasing the likelihood that this may be a low frequency benign variant in certain populations of origin (Genome Aggregation Consortium Feb 27, 2017). The p.Arg3972= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory criteria to be classified as benign.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.6
DANN
Benign
0.59
PhyloP100
0.65
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77634115; hg19: chr16-2140972; API